- Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer
- Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha
- Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells
- Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells
- Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines
- Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo
- Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man
- Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells
- Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells
- Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium